Viewing Study NCT01483950


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-03-10 @ 8:06 PM
Study NCT ID: NCT01483950
Status: COMPLETED
Last Update Posted: 2013-02-05
First Post: 2011-11-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypercholesterolaemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dyslipidemia View
None Statins View
None Total Cholesterol View
None Low density lipoprotein (LDL) cholesterol View
None High density lipoprotein (HDL) cholesterol View